Synthesis and studies of the ribofuranosides phenazazoles

Biopolymers and Cell

Volumn 13, Issue 6, 1997, Pages 453-459

  Makytruk, V L ^a   Shalamay, A S ^a   Kondratyuk, I V ^a  

^a INSTITUTE OF MOLECULAR BIOLOGY AND GENETICS   (Ukraine)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0342653515     PISSN: 02337657     EISSN: 19936842     Source Type: Journal    
DOI: 10.7124/bc.0004A6     Document Type: Article

References (9)

1. Uhlmaun E., Peymau A. Antisense-oligonucleotide: a new therapeutic principle // Chem. Rev,-1990-90, N 6.-P. 543-584.
2. Knorre D. G., Vlassov V. V. Antisense oligonucleotide derivatives as gene-targeted drugs // Biomed. Sci.-1990.-1, N 3.-P. 334-343.
3. Conkin B., Sasmor II., Digiorgio J., Warren W. Producting pharmaceutical-grade antisense DNA an evolving discipline // Millipore Bioforum (Technol. News for the Life Scientist).-Bedford, 1992.-Bull. N 2.-P. 2-4.
4. Helene C, Montenay-Carestier T., Saisofi T. et al. Oligonucleotides covalently linked to intercalating agents: a new class of gene reguiatore substances // Biochirnie.--1988.-67, N 7.-P. 777-783.
5. Keller T. H., Haher R. Synthesis and hybridizabion properties of oligonucleotides containing 2'-0-modified ribonucleotides // Nucl. Acids Res.-1993.-21, N 19.-P. 4499-4505.
6. Bischflerger N., Matteucci M. D. Synthesis of novel polycyclic nucleoside analogues, incorporation into oligonucleotides, and interaction with complementary sequences // J. Amer. Chem. Soc-1898.-I l l, N 8.-P. 3041-3046.
7. Cohen J. S., Farschtschi N., Polushin N. Design and biological properties of antisense oligonucleotide analogs // Genetically targeted research and therapeutics: Antisense and Gene therapy.-Keystone, 1993.-P. 12-18.
8. Zozulya V., Blagoi Yu., Lober G. et al. Fluorescence and binding properties of phenazine derivatives in complexe with polynucleotides of various base compositions and secondary structures // Biophys. Chem.-1997.-65.-P. 55-63.
9. Joues R.J., Lin K-Y., Milligan J. F. et al. Synthesis and binding properties of pyrimidine oligonucleotide analogs containing neutral phosphodiester replacementes // Genetically targeted research and therapeutigs: Antisense and Gene Therapy.-Keystone, 1993.-P. 19-24.